Re‐Evaluation of the Ideal Injury to Flap Time Frame for Lower Extremity Free Flap Reconstruction: Is 72 h Still the Gold Standard?
Microsurgery · 2026-05 · 46 (4)
DOI: 10.1002/micr.70228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microsurgery, online erschienen am 28.04.2026. Verfasst von Alexa Clark und 5 weiteren Autor:innen. Beteiligte Einrichtung: Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Free Tissue Flaps, Plastic Surgery Procedures, Leg Injuries, Limb Salvage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Traumatic lower extremity injuries often require free tissue transfer (FTT) for limb salvage when local tissue is insufficient. Traditionally, reconstruction within 72 h has been considered optimal; however, advancements in wound management and perioperative care have challenged this paradigm.
Objective
To evaluate outcomes of lower extremity FTT based on time from injury to reconstruction.
Methods
A retrospective review was performed on patients undergoing lower extremity FTT after trauma at a single Level 1 trauma center (2014–2022). Patients were grouped by time from injury to flap: (< 3 days, 4–21 days, 22–90 days, and > 90 days). Ninety nine percent of patients were managed with negative‐pressure wound therapy (NPWT) prior to definitive reconstruction. Outcomes included flap loss, complications, infection, osteomyelitis, nonunion, and amputation. Associations with comorbidities, surgical techniques, and fracture characteristics were assessed.
Results
Among 102 patients, timing of reconstruction showed no significant differences in flap loss ( p = 0.56), complications ( p = 0.42), nonunion ( p = 0.54), osteomyelitis ( p = 0.19), or amputation ( p = 0.58). No independent predictors of flap loss or complications were identified. Nonunion was associated with middle/proximal fracture levels ( p = 0.0092), Masquelet technique ( p = 0.0004), and higher Modified Frailty Index ( p = 0.05). Osteomyelitis correlated with male gender ( p = 0.01), proximal fracture level ( p = 0.0098), and Masquelet technique ( p = 0.0095). Amputation was associated with latissimus and radial forearm flaps ( p = 0.0081), ipsilateral femur fracture ( p = 0.0063), hypertension ( p = 0.011), and higher ASA score ( p = 0.0021).
Conclusion
In this series, delayed FTT beyond 72 h was not associated with increased flap loss or limb‐threatening complications. Delayed reconstruction may optimize patient and wound factors, though aggressive wound management is essential. Given the retrospective design, uneven group sizes, and small early reconstruction cohort, these findings should be interpreted cautiously. Further research with larger cohorts and long‐term outcomes is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Emory University School of Medicine, Atlanta, Georgia, USA.
- Emory University Division of Plastic and Reconstructive Surgery, Atlanta, Georgia, USA.
- Department of Plastic and Reconstructive Surgery, MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Alexa Clark, Makenna Ash
Zitieren
APA
Clark, A., Abdallah, C., Ash, M., Knaus, W., Brown, C., & Ghareeb, P. (2026). Re‐Evaluation of the Ideal Injury to Flap Time Frame for Lower Extremity Free Flap Reconstruction: Is 72 h Still the Gold Standard?. Microsurgery, 46(4). https://doi.org/10.1002/micr.70228
Vancouver
Clark A, Abdallah C, Ash M, Knaus W, Brown C, Ghareeb P. Re‐Evaluation of the Ideal Injury to Flap Time Frame for Lower Extremity Free Flap Reconstruction: Is 72 h Still the Gold Standard?. Microsurgery. 2026;46(4). doi:10.1002/micr.70228
BibTeX
@article{Clark2026,
author = {Clark, Alexa and Abdallah, Calvin and Ash, Makenna and Knaus, William and Brown, Ciara and Ghareeb, Paul},
title = {Re‐Evaluation of the Ideal Injury to Flap Time Frame for Lower Extremity Free Flap Reconstruction: Is 72 h Still the Gold Standard?},
journal = {Microsurgery},
year = {2026},
volume = {46},
number = {4},
doi = {10.1002/micr.70228}
}
EUVIMED